|
|
Article: Medical Science Systems Enters Into License Agreement with Glaxo Wellcome.
- Article from:
- Business Wire
- Article date:
- December 7, 1998
CopyrightCOPYRIGHT 1998 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SAN ANTONIO--(BW HealthWire)--Dec. 7, 1998--
BioFusion(R) Technology Developed by Medical Science Systems
Will Support Compound Screening Efforts
Medical Science Systems, Inc. (NASDAQ Symbol: MSSI) announced today that it has entered into a development and license agreement with Glaxo Wellcome Inc., a subsidiary of Glaxo Wellcome plc (NYSE: GLX), to develop a computer model in support of new compound screening.
Medical Science Systems' BioFusion proprietary technology provides a means of developing computer-based simulation models of large, complex biological systems which can assist in the interpretation of gene expression and ...